Advocacy News

SITC Hosts Advanced Biomarker Development and Clinical Translation: Computational Science in Immuno-oncology Webinar

By SITC Advocacy posted 13 days ago
This webinar on April 2 explored what b iomarker discovery for cancer immunotherapy entails using ...
0 comments

Announcing the publication of “Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocols”

By SITC Advocacy posted 27 days ago
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a comprehensive ...
0 comments

Kick-off of SITC’s 2025 Capitol Hill Visits!

By SITC Advocacy posted 03-03-2025
SITC is pleased to announce the kickoff of SITC’s 2025 Capitol Hill Visits! SITC members are meeting ...
0 comments

SITC Statement on NIH to Indirect Costs

By SITC Advocacy posted 02-19-2025
SITC released a statement addressing their concerns for the recent announcement from the National Institutes ...
0 comments

SITC Participates in Sign on Letter to Support the AKACA

By SITC Advocacy posted 12-11-2024
SITC has recently signed on to a letter from the Leukemia Lymphoma Society advocating congress to pass ...
0 comments
 
Cancer Research Policy User-Generated   Letter

SITC Hosts Tumor Biomarkers and Assessing PD-1: Increasing Access to IO Webinar

By SITC Advocacy posted 12-04-2024
This webinar on November 21st examined how biomarkers are used to define “PD-L1” positive patients around ...
0 comments
 
Cancer Research Policy Modality Webinar

Annual Meeting Session Highlight: Cellular Therapies/Regulatory/Manufacturing

By SITC Advocacy posted 11-06-2024
Cellular therapies offer great promise as a cancer therapy. They are living biological drugs, and often ...
0 comments
 
User-Generated   SITC2024

Tumor Infiltrating Lymphocytes (TIL) Symposium

By SITC Advocacy posted 11-04-2024
As part of the 39th Annual Meeting & Pre-Conference Programs (SITC 2024), the SITC Tumor Infiltrating ...
0 comments
 
User-Generated   SITC2024

SITC Hosts Monitoring Response to Cancer Immunotherapy: Increasing Access to IO Webinar

By SITC Advocacy posted 10-30-2024
This webinar on October 16th examined the importance of monitoring response to cancer immunotherapy, ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC Hosts Rationalized Patient Match and Clinical Trial Design with Large/Moderate Language Models on EHR Data: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 10-23-2024
Thousands of IO clinical trials are currently available to cancer patients, all of which are aiming to ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts Rare and Challenging Cases: Increasing Access to IO Webinar

By SITC Advocacy posted 10-09-2024
This webinar on September 26th examined how rare and challenging cases, such as extremes of age, immunocompromised, ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC Hosts Predicting Drug Resistance and Drug Repurposing with Imaging-Based AI: AI in Immuno-oncology Webinar

By SITC Advocacy posted 10-02-2024
Increased understanding of immunotherapy mechanisms of action may enhance researchers’ ability to circumvent ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Comments on FDA Guidance

By SITC Advocacy posted 09-26-2024
SITC has provided comment on the recently posted "Diversity Action Plans to Improve Enrollment of Participants ...
0 comments
 
Cancer Research Policy User-Generated   FDA

SITC Hosts Predicting Early Diagnosis and Response with Multimodal AI: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 09-16-2024
Earlier cancer diagnosis, as well as rapid determination of tumor response after treatment, could lead ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

SITC Hosts Immune Checkpoint Inhibitors: Increasing Access to IO Webinar

By SITC Advocacy posted 08-21-2024
This webinar on August 15th examined how immune checkpoint inhibitors are being utilized around the globe ...
0 comments
 
Cancer Research Policy Modality Webinar

SITC Hosts Social Determinants of Health with Large/Moderate Language Models on EHR Data: AI in Immuno-oncology Webinar

By SITC Advocacy posted 08-06-2024
Social determinants of health are becoming increasingly understood as having significant impact in immunotherapy ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO

Crisis in Clinical Research, a Commentary

By SITC Advocacy posted 07-22-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a commentary ...
0 comments
 
Cancer Research Policy User-Generated   Crisis   JITC

SITC Hosts Cell Therapy Administration: Increasing Access to IO Webinar

By SITC Advocacy posted 07-17-2024
This webinar on July 10th examined how cell therapies are being utilized around the globe and in resource ...
0 comments
 
Cancer Research Policy Modality Webinar

Call for Comment - Surrogate Endpoints Virtual Summit Executive Summary

By SITC Advocacy posted 07-12-2024
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the publication of a comprehensive ...
0 comments
 
Cancer Research Policy

SITC Hosts Opportunities and Implications for IO Using AI and Digital Pathology: AI in Immuno-Oncology Webinar

By SITC Advocacy posted 06-27-2024
Digital pathology is becoming an increasingly important technique for immunotherapy drug development ...
0 comments
 
Cancer Research Policy Modality Webinar User-Generated   AIinIO